Inhibition of Influenza A Virus Replication by a Mammalian Specific Small RNA

Project: National Science and Technology CouncilNational Science and Technology Council Academic Grants

Project Details

Abstract

The influenza A virus has been a global public health concerns since the Spanish flu oubreak in the1918s; however, broad-spectrum antiviral drug and effective treatments have not yet been fully developed because flu virus has high mutation rate that would generate drug-resistant virus. Here we would like to use microRNA antagonist as an antiviral agent. Numerous studies have shown that miRNA affects virus replication by regulating viral or cellular gene expression, indicating that miRNA might regulate mutiple gene expressions to control virus growth. In our preliminary results, we identified human-specific hsa-miR-1290 as a positive regulator of influenza A virus replication and the viral titers decreased when we over-expressed the hsa-miR-1290 inhibitor in cells. This proposal focuses on the mechanism that influenza-A-virus-inducing hsa-miR-1290 and hsa-miR-1290 promotes influenza A virus replication. In addition, hsa-miR-1290 is a human-specific miRNA that we cannot study further in mouse models; therefore, we will estabilish a primary human respiratory epithelial cell culture system to conduct additional studies. We anticipate that the hsa-miR-1290 inhibitor will be a feasible broad-spectrum and effective antiviral drug. In addition, the human-specific hsa-miR-1290 could facilitate exploring additional human-specific factors invoved in influenza A virus replication, which could explain why some influenza A virus strains have more severe symptoms in humans than in birds or other animals. The following are the 4 specific aims in the proposal: Aim 1: To study the mechanism of the influenza A virus that induces hsa-miR-1290 expression. Aim 2: Examine whether hsa-miR-1290 promotes influenza A virus replication by targeting the viral genome. Aim 3: Examine whether hsa-miR-1290 promotes influenza A virus replication by targeting cellular genes. Aim 4: Validate regulation of hsa-miR-1290 on influenza A virsus replication in primary human respiratory epithelial cells.

Project IDs

Project ID:PC10501-2084
External Project ID:MOST104-2320-B182-026-MY3
StatusFinished
Effective start/end date01/08/1631/07/17

Keywords

  • influenza A virus
  • human-specific miRNA
  • antiviral agent

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.